SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Pre-tax earnings
5Y CAGR
-8.0%/yr
Long-term compound
Percentile
P83
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $13.27M | +138.9% |
| 2024 | $-34.11M | +19.2% |
| 2023 | $-42.19M | -125.5% |
| 2022 | $-18.72M | -9.2% |
| 2021 | $-17.14M | -185.2% |
| 2020 | $20.12M | +323.9% |
| 2019 | $-8.99M | - |